The JAK/STAT pathway in obesity and diabetes

Esteban N. Gurzov, William J Stanley, Evan G. Pappas, Helen E Thomas, Daniel J. Gough

Research output: Contribution to journalReview ArticleOtherpeer-review

Abstract

Diabetes mellitus are complex, multi-organ metabolic pathologies characterized by hyperglycemia. Emerging evidence shows that the highly conserved and potent JAK/STAT signaling pathway is required for normal homeostasis, and, when dysregulated, contributes to the development of obesity and diabetes. In this review, we analyze the role of JAK/STAT activation in the brain, liver, muscle, fat and pancreas, and how this affects the course of the disease. We also consider the therapeutic implications of targeting the JAK/STAT pathway in treatment of obesity and diabetes.

Original languageEnglish
Pages (from-to)3002-3015
Number of pages14
JournalFEBS Journal
DOIs
Publication statusPublished - 1 Aug 2016

Keywords

  • adipose tissue
  • brain
  • cytokines
  • diabetes
  • hormones
  • JAK/STAT signaling pathway
  • liver
  • muscle
  • obesity
  • pancreas

Cite this

Gurzov, E. N., Stanley, W. J., Pappas, E. G., Thomas, H. E., & Gough, D. J. (2016). The JAK/STAT pathway in obesity and diabetes. FEBS Journal, 3002-3015. https://doi.org/10.1111/febs.13709
Gurzov, Esteban N. ; Stanley, William J ; Pappas, Evan G. ; Thomas, Helen E ; Gough, Daniel J. / The JAK/STAT pathway in obesity and diabetes. In: FEBS Journal. 2016 ; pp. 3002-3015.
@article{6a6fc3162deb49138e1da347a1a7c7e3,
title = "The JAK/STAT pathway in obesity and diabetes",
abstract = "Diabetes mellitus are complex, multi-organ metabolic pathologies characterized by hyperglycemia. Emerging evidence shows that the highly conserved and potent JAK/STAT signaling pathway is required for normal homeostasis, and, when dysregulated, contributes to the development of obesity and diabetes. In this review, we analyze the role of JAK/STAT activation in the brain, liver, muscle, fat and pancreas, and how this affects the course of the disease. We also consider the therapeutic implications of targeting the JAK/STAT pathway in treatment of obesity and diabetes.",
keywords = "adipose tissue, brain, cytokines, diabetes, hormones, JAK/STAT signaling pathway, liver, muscle, obesity, pancreas",
author = "Gurzov, {Esteban N.} and Stanley, {William J} and Pappas, {Evan G.} and Thomas, {Helen E} and Gough, {Daniel J.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1111/febs.13709",
language = "English",
pages = "3002--3015",
journal = "FEBS Journal",
issn = "1742-464X",
publisher = "Wiley-Blackwell",

}

Gurzov, EN, Stanley, WJ, Pappas, EG, Thomas, HE & Gough, DJ 2016, 'The JAK/STAT pathway in obesity and diabetes', FEBS Journal, pp. 3002-3015. https://doi.org/10.1111/febs.13709

The JAK/STAT pathway in obesity and diabetes. / Gurzov, Esteban N.; Stanley, William J; Pappas, Evan G.; Thomas, Helen E; Gough, Daniel J.

In: FEBS Journal, 01.08.2016, p. 3002-3015.

Research output: Contribution to journalReview ArticleOtherpeer-review

TY - JOUR

T1 - The JAK/STAT pathway in obesity and diabetes

AU - Gurzov, Esteban N.

AU - Stanley, William J

AU - Pappas, Evan G.

AU - Thomas, Helen E

AU - Gough, Daniel J.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Diabetes mellitus are complex, multi-organ metabolic pathologies characterized by hyperglycemia. Emerging evidence shows that the highly conserved and potent JAK/STAT signaling pathway is required for normal homeostasis, and, when dysregulated, contributes to the development of obesity and diabetes. In this review, we analyze the role of JAK/STAT activation in the brain, liver, muscle, fat and pancreas, and how this affects the course of the disease. We also consider the therapeutic implications of targeting the JAK/STAT pathway in treatment of obesity and diabetes.

AB - Diabetes mellitus are complex, multi-organ metabolic pathologies characterized by hyperglycemia. Emerging evidence shows that the highly conserved and potent JAK/STAT signaling pathway is required for normal homeostasis, and, when dysregulated, contributes to the development of obesity and diabetes. In this review, we analyze the role of JAK/STAT activation in the brain, liver, muscle, fat and pancreas, and how this affects the course of the disease. We also consider the therapeutic implications of targeting the JAK/STAT pathway in treatment of obesity and diabetes.

KW - adipose tissue

KW - brain

KW - cytokines

KW - diabetes

KW - hormones

KW - JAK/STAT signaling pathway

KW - liver

KW - muscle

KW - obesity

KW - pancreas

UR - http://www.scopus.com/inward/record.url?scp=84983294413&partnerID=8YFLogxK

U2 - 10.1111/febs.13709

DO - 10.1111/febs.13709

M3 - Review Article

SP - 3002

EP - 3015

JO - FEBS Journal

JF - FEBS Journal

SN - 1742-464X

ER -

Gurzov EN, Stanley WJ, Pappas EG, Thomas HE, Gough DJ. The JAK/STAT pathway in obesity and diabetes. FEBS Journal. 2016 Aug 1;3002-3015. https://doi.org/10.1111/febs.13709